Clinical study of Qinggan Hewei Prescription in treating refractory gastroesophageal reflux disease of liver and stomach gloomy heat type

Beijing Pinggu District Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) Aged 18-65;
•(2) The diagnosis was consistent with non-erosive RGERD;
•(3) TCM syndrome differentiation is consistent with the syndrome of liver and stomach stagnation heat;
•(4) Gastroscopy was basically normal, allowing superficial gastritis or atrophic gastritis;
•(5) Consent to 24h esophageal ph-impedance test, and sign informed consent.

•(1) A history of gastric, esophageal and duodenal operations.
•(2) There are drug esophagitis, fungal esophagitis, corrosive esophagitis, achalasia from the cardia, hiatal hernia, eosinophilic esophagitis, immune-related esophageal diseases.
•(3) Suspected or confirmed malignant diseases or any early warning symptoms, and organic diseases of digestive tract (digestive ulcer, digestive tract tumor, inflammatory bowel disease, etc.) were found in previous examinations.
•(4) have serious primary heart, liver, lung, kidney, pancreas, liver or serious diseases affecting their survival.
•(5) Legally prescribed patients with disabilities (blindness, deafness, muteness, intellectual handicap, mental handicap and physical disability, etc.).
•(6) Suspected or confirmed history of alcohol and drug abuse.
•(7) Allergic constitution, such as the history of allergic to two or more drugs or food; Or known to be allergic to the drug ingredient.
•(8) Patients with mental system diseases, whose symptoms are not clearly expressed or who cannot communicate with doctors normally.
•(9) pregnant women or breast-feeding women, or women planning to become pregnant within 3 months.
•(10) Patients with RGERD due to poor compliance.

发起方

Beijing Pinggu District Hospital of Traditional Chinese Medicine